Roy G. SMITHt

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

T. Eberlein, I. Yoshino, G. Peoples, 1995, Proceedings of the National Academy of Sciences of the United States of America.